In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Life's loss is Illumina's gain, as Ion Torrent founder leaves

This article was originally published in Clinica

Executive Summary

Jonathan Rothberg has resigned as CEO of Life Technologies’ subsidiary Ion Torrent, its next-generation DNA sequencing business, “to pursue other opportunities”. The move is “not a surprise given Dr Rothberg’s entrepreneurial background”, according to Goldman Sachs analyst Isaac Ro, who noted: “Since the announcement of the proposed [Thermo Fisher Scientific/Life] merger, investors have questioned what Dr Rothberg’s position might be in the combined company.” Thermo Fisher agreed to buy Life for $13.6 billion (excluding debt) in April (, 16 April 2013).






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts